← Leaderboards
Cindy L Bryce
University Of Pittsburgh At Pittsburgh
$924,544
Attributed
$924,544
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $157.1K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$892,284 · 2
AHRQ$32,260 · 1
By mechanism
K25$603,923 · 1
R21$288,361 · 1
R13$32,260 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Karen A Matthews$36,358,765
- Maria Mori Brooks$44,871,550
- Donghun Shin$7,694,142
- Daniel S McConnell$24,789,449
- Martica Helon Hall$9,756,546
Others in their field
Top investigators on “Behavioral /Social Science Research Tag”
- Willard Cates · Family Health International$73,520,657
- Norman Wolmark · Nsabp Foundation, Inc.$67,161,981
- Robert J Willis · University Of Michigan At Ann Arbor$64,770,100
- Stephen A Spector · University Of California, San Diego$59,875,103
- Lloyd D Johnston · University Of Michigan At Ann Arbor$33,778,046
- Gregory H Reaman · National Childhood Cancer Foundation$29,150,052
Research focus
Behavioral /Social Science Research TagClinical ResearchEpidemiologyGender DifferenceHuman DataRacial /Ethnic DifferenceSocioeconomicsLiver FailureLiver TransplantationData Collection Methodology /EvaluationStatistics /Biometry
Grant awards (8)
A Conference Grant to Support the 29th Annual Meeting of SMDM$32,260
R13 · FY2007 · HS · contact PI
Assessing Individual Preferences for End-of-Life Care$157,060
R21 · FY2006 · AG · contact PI
Assessing Individual Preferences for End-of-Life Care$131,301
R21 · FY2005 · AG
END-STAGE LIVER DISEASE/PREVALENCE &TREATMENT VARIATION$119,510
K25 · FY2004 · DK
END-STAGE LIVER DISEASE/PREVALENCE &TREATMENT VARIATION$124,737
K25 · FY2003 · DK
END-STAGE LIVER DISEASE/PREVALENCE &TREATMENT VARIATION$122,085
K25 · FY2002 · DK
END-STAGE LIVER DISEASE/PREVALENCE &TREATMENT VARIATION$121,281
K25 · FY2001 · DK
END-STAGE LIVER DISEASE/PREVALENCE &TREATMENT VARIATION$116,310
K25 · FY2000 · DK